Peptic Ulcer Hemorrhage Clinical Trial
Official title:
Phase 3 Study of Prospective Randomized Trial Comparing Adjunctive High Dose Omeprazole Infusion Against Scheduled Second Endoscopy in the Prevention of Peptic Ulcer Rebleeding After Therapeutic Endoscopy
A prospective randomized study to compare the adjunctive use of high dose omeprazole infusion against scheduled second endoscopy in prevention of peptic ulcer rebleeding after therapeutic endoscopy.
We have previously performed a prospective randomized controlled trial on the effect of
scheduled second endoscopy upon peptic ulcer rebleeding. We found that the rate of recurrent
bleeding was significantly reduced from 13.8% to 5% with a scheduled second endoscopy and
appropriate therapy performed within 24 hours after initial hemostasis.
When we look at the studies in the literature employing proton pump inhibitors (PPI)
infusion after primary endoscopic therapy, we found that there was also a significant
reduction in the rate of rebleeding, the number of operation performed and the transfusion
requirement.
Controversy exists regarding the optimal strategy to minimize recurrent peptic ulcer
bleeding after successful endoscopic hemostasis. A recent cost-effective analysis on various
strategies showed that selective scheduled second endoscopy strategy was probably the most
effective and least expensive to prevent recurrent peptic ulcer bleeding.
We conduct a randomized trial on the cost-effectiveness of using omeprazole infusion vs
scheduled second endoscopy on the management of bleeding peptic ulcers.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01125852 -
Supplementary Angiographic Embolization for Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT00840008 -
The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding
|
Phase 4 | |
Terminated |
NCT00164905 -
Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage
|
N/A | |
Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
Completed |
NCT03362281 -
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
|
Phase 3 | |
Completed |
NCT04211194 -
Registry for Upper Gastrointestinal Bleeding
|
||
Completed |
NCT01241266 -
China Survey of Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT00037570 -
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
|
Phase 2 | |
Completed |
NCT00731601 -
Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
|
Phase 4 | |
Completed |
NCT05248321 -
Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding
|
N/A | |
Recruiting |
NCT00687336 -
Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
|
Phase 4 | |
Not yet recruiting |
NCT06273384 -
Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
|
||
Terminated |
NCT00165009 -
Resolution Endoclips Vs Epinephrine Injection and Heater Probe
|
Phase 3 | |
Completed |
NCT03163680 -
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
|
||
Completed |
NCT00279123 -
Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers
|
Phase 4 | |
Completed |
NCT03362268 -
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
|
Phase 2 | |
Completed |
NCT00573924 -
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
|
N/A | |
Withdrawn |
NCT02724150 -
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
|
Phase 4 | |
Active, not recruiting |
NCT04536428 -
ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding
|
N/A | |
Completed |
NCT02197039 -
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
|